Ringelstein, M. and Asseyer, S. and Lindenblatt, G. and Fischer, K. and Pul, R. and Ozalp, S. -H. and Lohmann, L. and Giglhuber, K. and Haeussler, V. and Karenfort, M. and Hellwig, K. and Paul, F. and Bellmann-Strobl, J. and Otto, C. and Ruprecht, K. and Ziemssen, T. and Emmer, A. and Rothhammer, V. and Nickel, F. T. and Angstwurm, Klemens and Linker, Ralf and Laurent, S. and Warnke, C. and Jarius, S. and Kuhnke, M. K. and Wildemann, B. and Wolff, S. and Seipelt, M. and Yalachkov, Y. and Retzlaff, N. and Zettl, U. K. and Rommer, P. and Kowarik, M. C. and Wickel, J. and Geis, C. and Huemmert, M. W. and Trebst, C. and Senel, M. and Klotz, L. and Kleinschnitz, C. and Meuth, S. G. and Aktas, O. and Berthele, A. and Ayzenberg, I.
(2022)
Eculizumab use in neuromyelitis optica spectrum disorders: real-world evidence from Germany and Austria.
In: 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, October 26-28, 2022, Amsterdam, NETHERLANDS.
Full text not available from this repository.
Actions (login required)
 |
View Item |
